Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration
Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...
Автори: | Eleonora M. Lad, Robert P. Finger, Robyn Guymer |
---|---|
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Adis, Springer Healthcare
2023-09-01
|
Серія: | Ophthalmology and Therapy |
Предмети: | |
Онлайн доступ: | https://doi.org/10.1007/s40123-023-00807-9 |
Схожі ресурси
Схожі ресурси
-
Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
за авторством: Treefa Shwani, та інші
Опубліковано: (2023-11-01) -
Age-Related Macular Degeneration: Classification and Pathogenesis
за авторством: İmren Akkoyun
Опубліковано: (2014-12-01) -
Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
за авторством: Reem H. ElSheikh, та інші
Опубліковано: (2022-11-01) -
Serum lipids in adults with late age-related macular degeneration: a case-control study
за авторством: Richard D. Semba, та інші
Опубліковано: (2019-01-01) -
Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
за авторством: João Estarreja, та інші
Опубліковано: (2024-07-01)